Search liu.se

Our research concerns epidemiological data and information processing in connection with infectious disease outbreaks at local and regional level.

The Nucleic Acids Technologies Lab explores the use of nucleic acids as biorecognition molecules to develop highly specific and sensitive systems, with various detection modalities.

Childhood immune maturation and allergy development: Epigenetic regulation by maternal immunity and microbial exposure during pregnancy.

WCMM at LiU focuses on the medicine-technology interface, and build upon our existing strengths in research within medical technology, materials science and bioengineering.

The aim of the N-forte trial is to explore how breast milk composition influences the development of NEC, sepsis and neurological impairment in extremely preterm infants in order to improve future treatments in this patient group.

Center for Social and Affective Neuroscience (CSAN) integrates knowledge and methodology from different areas of basic and clinical neuroscience.

Our research explores how infections like COVID-19 and tuberculosis alter DNA through epigenetic changes. Tuberculosis exposure leaves marks in immune and other cells. COVID-19 also rewires immune cell DNA, offering diagnostic insights.

Our general aim is to individualise and thereby optimize management of clinical TB by new methods and strategies. The research group consists of specialists in tuberculosis from different professions.

LiU researchers are among the first in the world to have grown human nasal tissue from stem cells. It is used to study how different viruses infect the airways.

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system. This is the conclusion of a study carried out by researchers at LiU.